---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-103530"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2026-09-25T20:30:25+00:00"
generated_at: "2026-10-12T13:24:04.472903+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Rocket One sets Dec 17, 2026 annual meeting; shareholder proposals due Oct 1

## Summary
- Board set the 2026 annual meeting for December 17, 2026, more than 25 days after the one-year anniversary of the 2025 meeting held August 5, 2025.
- Bylaw advance-notice nominations or business must reach the Secretary at 720 Monroe Street, Suite E514, Hoboken, NJ 07030 by close of business October 5, 2026.
- Rule 14a-8 proposals for inclusion in the 2026 proxy statement are due by close of business October 1, 2026.
- Universal proxy notices under Rule 14a-19 must be received by October 19, 2026, in addition to Bylaw advance-notice requirements.
- CEO Robb Knie signed the report dated September 25, 2026; no other corporate actions or financial terms were disclosed.

## SEC filing metadata
- accession: 0001213900-26-103530
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2026-09-25T20:30:25+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390026103530/0001213900-26-103530-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390026103530/ea0306677-8k_rocket.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-103530
- JSON: https://secwatch.observer/filing/0001213900-26-103530.json
- Plain text: https://secwatch.observer/filing/0001213900-26-103530.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
